ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 42 filers reported holding AC IMMUNE SA in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of AC IMMUNE SA
ValueSharesWeighting
Q3 2021$320,000
-15.3%
47,7150.0%0.00%
Q2 2021$378,000
-61.2%
47,715
-62.8%
0.00%
-100.0%
Q1 2021$975,000
+48.9%
128,098
+1.1%
0.00%0.0%
Q4 2020$655,000
-33.5%
126,707
-37.2%
0.00%
-50.0%
Q3 2020$985,000
-27.3%
201,919
+0.3%
0.00%0.0%
Q2 2020$1,355,000
-2.6%
201,3190.0%0.00%
-50.0%
Q1 2020$1,391,000
+961.8%
201,319
+1207.3%
0.00%
Q4 2019$131,000
-24.3%
15,400
-28.8%
0.00%
Q3 2018$173,00021,6440.00%
Other shareholders
AC IMMUNE SA shareholders Q2 2020
NameSharesValueWeighting ↓
BVF INC/IL 7,428,379$21,170,8800.57%
Avidity Partners Management LP 2,969,800$8,463,9300.34%
PLATINUM INVESTMENT MANAGEMENT LTD 1,322,462$3,769,0170.15%
Eversept Partners, LP 124,589$355,0790.03%
COHEN LAWRENCE B 12,850$36,6230.02%
Banque Cantonale Vaudoise 80,701$2310.01%
Renaissance Technologies 425,179$1,2120.00%
Handelsbanken Fonder AB 101,064$2880.00%
Tower Research Capital LLC (TRC) 19,638$55,9680.00%
Compagnie Lombard Odier SCmA 10,000$28,5000.00%
View complete list of AC IMMUNE SA shareholders